Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Children with Sickle Cell Disease and Thalassemia: a Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Shenoy S, Angelucci E, Arnold SD, Baker KS, Bhatia M, Bresters D, Dietz AC, De La Fuente J, Duncan C, Gaziev J, King AA, Pulsipher MA, Smith A, Walters MC.

Biol Blood Marrow Transplant. 2017 Jan 5. pii: S1083-8791(17)30079-4. doi: 10.1016/j.bbmt.2017.01.009. [Epub ahead of print]

PMID:
28065838
2.

Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.

King AA, Seidel K, Di C, Leisenring WM, Perkins SM, Krull KR, Sklar CA, Green DM, Armstrong GT, Zeltzer LK, Wells E, Stovall M, Ullrich NJ, Oeffinger KC, Robison LL, Packer RJ.

Neuro Oncol. 2016 Dec 29. pii: now242. doi: 10.1093/neuonc/now242. [Epub ahead of print]

PMID:
28039368
3.
4.

Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database.

Fischer-Valuck BW, Chen I, Srivastava AJ, Floberg JM, Rao YJ, King AA, Shinohara ET, Perkins SM.

Cancer. 2016 Nov 2. doi: 10.1002/cncr.30405. [Epub ahead of print]

PMID:
27861763
5.

The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology.

King AA, Vesely SK, Elwood J, Basso J, Carson K, Sung L.

Blood. 2016 Dec 22;128(25):2881-2885. doi: 10.1182/blood-2016-06-724211. No abstract available.

PMID:
27784672
6.

Feasibility of a Community-Based Sickle Cell Trait Testing and Counseling Program.

Housten AJ, Abel RA, Lindsey T, King AA.

J Health Dispar Res Pract. 2016 Fall;9(3). pii: 1.

7.

A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell disease.

Fields ME, Hoyt-Drazen C, Abel R, Rodeghier MJ, Yarboi JM, Compas BE, King AA.

Pediatr Blood Cancer. 2016 Dec;63(12):2131-2138. doi: 10.1002/pbc.26164.

PMID:
27509845
8.

Community Health Workers as Support for Sickle Cell Care.

Hsu LL, Green NS, Donnell Ivy E, Neunert CE, Smaldone A, Johnson S, Castillo S, Castillo A, Thompson T, Hampton K, Strouse JJ, Stewart R, Hughes T, Banks S, Smith-Whitley K, King A, Brown M, Ohene-Frempong K, Smith WR, Martin M.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S87-98. doi: 10.1016/j.amepre.2016.01.016.

9.

NCCN Guidelines Insights: Survivorship, Version 1.2016.

Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH, Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 Jun;14(6):715-24.

PMID:
27283164
10.

Cutaneous leishmaniasis: an emerging infectious disease in travelers.

Ergen EN, King AH, Tuli M.

Cutis. 2015 Oct;96(4):E22-6.

PMID:
26682298
11.

Prevalence of Developmental Delay and Contributing Factors Among Children With Sickle Cell Disease.

Drazen CH, Abel R, Gabir M, Farmer G, King AA.

Pediatr Blood Cancer. 2016 Mar;63(3):504-10. doi: 10.1002/pbc.25838.

PMID:
26575319
12.

Association of social-environmental factors with cognitive function in children with sickle cell disease.

Yarboi J, Compas BE, Brody GH, White D, Rees Patterson J, Ziara K, King A.

Child Neuropsychol. 2015 Nov 15:1-18. [Epub ahead of print]

PMID:
26568287
13.

Youth with Sickle Cell Disease: Genetic and Sexual Health Education Needs.

Housten AJ, Abel RA, Dadekian J, Schwieterman K, Jason D, King AA.

Am J Health Behav. 2015 Nov;39(6):856-65. doi: 10.5993/AJHB.39.6.13.

14.

Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.

King AA, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi RJ, Grimley M, Abraham A, Dioguardi J, Chan KW, Douglas D, Adams R, Andreansky M, Anderson E, Gilman A, Chaudhury S, Yu L, Dalal J, Hale G, Cuvelier G, Jain A, Krajewski J, Gillio A, Kasow KA, Delgado D, Hanson E, Murray L, Shenoy S.

Am J Hematol. 2015 Dec;90(12):1093-8. doi: 10.1002/ajh.24183.

15.

Transition Needs of Adolescents With Sickle Cell Disease.

Abel RA, Cho E, Chadwick-Mansker KR, D'Souza N, Housten AJ, King AA.

Am J Occup Ther. 2015 Mar-Apr;69(2):6902350030p1-5. doi: 10.5014/ajot.2015.013730.

16.

The Association of Cytokine Levels With Cognitive Function in Children With Sickle Cell Disease and Normal MRI Studies of the Brain.

Andreotti C, King AA, Macy E, Compas BE, DeBaun MR.

J Child Neurol. 2015 Sep;30(10):1349-53. doi: 10.1177/0883073814563140.

17.

Survivorship: screening for cancer and treatment effects, version 2.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Nov;12(11):1526-31.

18.

Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.

Beverung LM, Strouse JJ, Hulbert ML, Neville K, Liem RI, Inusa B, Fuh B, King A, Meier ER, Casella J, DeBaun MR, Panepinto JA; SIT trial investigators..

Am J Hematol. 2015 Feb;90(2):139-43. doi: 10.1002/ajh.23877.

19.

Insect heat shock proteins during stress and diapause.

King AM, MacRae TH.

Annu Rev Entomol. 2015 Jan 7;60:59-75. doi: 10.1146/annurev-ento-011613-162107. Review.

PMID:
25341107
20.

Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA; National Comprehensive Cancer Network..

J Natl Compr Canc Netw. 2014 Oct;12(10):1396-406.

Items per page

Supplemental Content

Loading ...
Support Center